Insight Inv LLC’s AbbVie ABBV Stock Holding History

Insight Inv LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Buy	1,328 +7	+0.5%	+$1.51K	0.16%	74
2026 Q1	$287K	Buy	1,321 +5	+0.4%	+$1.11K	0.16%	77
2025 Q4	$301K	Sell	1,316 -204	-13%	-$46.5K	0.17%	80
2025 Q3	$352K	Sell	1,520 -178	-10%	-$36.2K	0.21%	78
2025 Q2	$315K	Sell	1,698 -23	-1%	-$4.28K	0.21%	76
2025 Q1	$361K	Buy	1,721 +19	+1%	+$3.69K	0.25%	74
2024 Q4	$302K	Sell	1,702 -1,448	-46%	-$266K	0.21%	81
2024 Q3	$622K	Hold	3,150	–	–	0.52%	56
2024 Q2	$540K	Hold	3,150	–	–	0.47%	58
2024 Q1	$574K	Hold	3,150	–	–	0.5%	58
2023 Q4	$488K	Hold	3,150	–	–	0.48%	57
2023 Q3	$458K	Hold	3,150	–	–	0.51%	57
2023 Q2	$424K	Hold	3,150	–	–	0.44%	59
2023 Q1	$502K	Hold	3,150	–	–	0.54%	61
2022 Q4	$509K	Hold	3,150	–	–	0.51%	63
2022 Q3	$423K	Hold	3,150	–	–	0.47%	64
2022 Q2	$482K	Sell	3,150 -17	-0.5%	-$2.6K	0.49%	63
2022 Q1	$513K	Sell	3,167 -400	-11%	-$58.1K	0.47%	63
2021 Q4	$483K	Buy	+3,567	New	+$421K	0.44%	65

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Insight Inv LLC's ABBV Position: Q2 2026 in Review

Insight Inv LLC increased its AbbVie (ABBV) stake by 0.53% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,328 shares worth $334K. The position accounts for 0.16% of the portfolio, ranked #74.

Insight Inv LLC first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $622K in Q3 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Insight Inv LLC held 1,328 shares of AbbVie worth $334K as of Q2 2026.
Insight Inv LLC bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
AbbVie made up 0.16% of Insight Inv LLC's portfolio in Q2 2026, its #74 holding.
Insight Inv LLC first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Insight Inv LLC's AbbVie position peaked at $622K in Q3 2024.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Insight Inv LLC's 13F filing for Q2 2026, filed 24 Jul 2026.